Promising Materials in the Fight against Healthcare-Associated Infections: Antibacterial Properties of Chitosan-Polyhedral Oligomeric Silsesquioxanes Hybrid Hydrogels.
antibacterial activity
chitosan
chitosan-POSS
healthcare-associated infections
hydrogel
Journal
Journal of functional biomaterials
ISSN: 2079-4983
Titre abrégé: J Funct Biomater
Pays: Switzerland
ID NLM: 101570734
Informations de publication
Date de publication:
17 Aug 2023
17 Aug 2023
Historique:
received:
20
07
2023
revised:
08
08
2023
accepted:
13
08
2023
medline:
25
8
2023
pubmed:
25
8
2023
entrez:
25
8
2023
Statut:
epublish
Résumé
New technologies and materials could help in this fight against healthcare-associated infections. As the majority of these infections are caused by antibiotic-resistant bacteria, the development of materials with intrinsic antibacterial properties is a promising field of research. We combined chitosan (CS), with antibacterial properties, with polyhedral oligomeric silsesquioxanes (POSS), a biocompatible polymer with physico-chemical, mechanical, and rheological properties, creating a hydrogel using cross-linking agent genipin. The antibacterial properties of CS and CS-POSS hydrogels were investigated against nosocomial Gram-positive and Gram-negative bacteria both in terms of membrane damage and surface charge variations, and finally, the anti-biofilm property was studied through confocal microscopy. Both materials showed a good antibacterial capacity against all analyzed strains, both in suspension, with % decreases between 36.36 and 73.58 for CS and 29.86 and 66.04 for CS-POSS, and in plates with % decreases between 55.29 and 78.32 and 17.00 and 53.99 for CS and CS-POSS, respectively. The treated strains compared to the baseline condition showed an important membrane damage, which also determined a variation of surface charges, and finally, for both hydrogels, a remarkable anti-biofilm property was highlighted. Our findings showed a possible future use of these biocompatible materials in the manufacture of medical and surgical devices with intrinsic antibacterial and anti-biofilm properties.
Identifiants
pubmed: 37623672
pii: jfb14080428
doi: 10.3390/jfb14080428
pmc: PMC10456118
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Dalton Trans. 2016 Nov 1;45(43):17082-17086
pubmed: 27603221
J Mater Sci Mater Med. 2017 Dec 01;29(1):1
pubmed: 29196900
Int J Mol Sci. 2021 Jul 12;22(14):
pubmed: 34299068
J Microbiol Immunol Infect. 2020 Aug;53(4):525-531
pubmed: 31607570
Carbohydr Polym. 2018 Jan 15;180:168-174
pubmed: 29103492
Antimicrob Resist Infect Control. 2022 Feb 19;11(1):38
pubmed: 35183259
Chem Rev. 2010 Apr 14;110(4):2081-173
pubmed: 20225901
Materials (Basel). 2021 Oct 11;14(20):
pubmed: 34683575
Gels. 2022 Aug 12;8(8):
pubmed: 36005104
ACS Appl Mater Interfaces. 2023 Jan 11;15(1):354-363
pubmed: 36534480
Nanomaterials (Basel). 2020 Oct 05;10(10):
pubmed: 33027891
Anal Biochem. 1993 Jun;211(2):240-1
pubmed: 8317699
Antibiotics (Basel). 2020 May 19;9(5):
pubmed: 32438547
Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3645-3663
pubmed: 37140315
Curr Med Chem. 2020;27(10):1580-1599
pubmed: 30215330
Mar Drugs. 2021 Aug 25;19(9):
pubmed: 34564141
Molecules. 2020 Nov 03;25(21):
pubmed: 33153228
Int J Nanomedicine. 2018 Apr 12;13:2217-2263
pubmed: 29695904
Materials (Basel). 2022 Nov 18;15(22):
pubmed: 36431692
Int J Biol Macromol. 2020 Jan 1;142:643-657
pubmed: 31622724
Br J Nurs. 2021 Apr 22;30(8):S4-S9
pubmed: 33876689
Future Microbiol. 2014;9(2):175-88
pubmed: 24571072
Curr Microbiol. 2016 May;72(5):518-28
pubmed: 26750122
J Hosp Infect. 2013 Sep;85(1):8-16
pubmed: 23920442
CMAJ. 2016 Mar 1;188(4):243-244
pubmed: 26438015
Molecules. 2023 Apr 05;28(7):
pubmed: 37050003
Antimicrob Resist Infect Control. 2020 Oct 20;9(1):162
pubmed: 33081846
Colloids Surf B Biointerfaces. 2013 Feb 1;102:795-802
pubmed: 23107958
Molecules. 2021 Nov 25;26(23):
pubmed: 34885715
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1266-1278
pubmed: 30779096
Annu Rev Food Sci Technol. 2016;7:245-66
pubmed: 26735797
J Diabetes Res. 2022 May 17;2022:3588297
pubmed: 35620571
J Hosp Infect. 2021 Aug;114:10-22
pubmed: 34301392
Biomed Res Int. 2015;2015:821279
pubmed: 26504833
Biomed Mater Eng. 2014;24(1 Suppl):63-73
pubmed: 24928919
Carbohydr Polym. 2016 Oct 20;151:172-188
pubmed: 27474556
J Mater Chem B. 2019 Feb 7;7(5):709-729
pubmed: 32254845
Proc Inst Mech Eng H. 2014 Oct;228(10):1083-99
pubmed: 25406229
Gels. 2022 Dec 30;9(1):
pubmed: 36661802
Int J Microbiol. 2023 May 11;2023:8841509
pubmed: 37214152
Materials (Basel). 2018 Sep 12;11(9):
pubmed: 30213057
Sci Rep. 2018 Jan 11;8(1):500
pubmed: 29323212
Materials (Basel). 2021 Feb 08;14(4):
pubmed: 33567675
Antibiotics (Basel). 2021 Jan 04;10(1):
pubmed: 33406652
Pharmaceutics. 2023 Jun 13;15(6):
pubmed: 37376166
Infect Control Hosp Epidemiol. 2011 Jul;32(7):687-99
pubmed: 21666400
Materials (Basel). 2019 Jul 20;12(14):
pubmed: 31330857
Carbohydr Polym. 2022 Jan 15;276:118718
pubmed: 34823762
J Craniofac Surg. 2018 Oct;29(7):1788-1793
pubmed: 30157141
J Med Microbiol. 2015 Apr;64(Pt 4):323-334
pubmed: 25670813
Pathogens. 2021 Mar 25;10(4):
pubmed: 33805913
Carbohydr Polym. 2022 Feb 1;277:118871
pubmed: 34893276
J Colloid Interface Sci. 2023 Sep 15;646:576-586
pubmed: 37210905
J Mater Sci Mater Med. 2011 Jun;22(6):1365-74
pubmed: 21505828
Int J Biol Macromol. 2022 Apr 15;204:441-456
pubmed: 35151707
Antibiotics (Basel). 2023 Feb 02;12(2):
pubmed: 36830221
ACS Omega. 2021 Aug 19;6(34):21994-22010
pubmed: 34497894
Surgeon. 2015 Feb;13(1):52-8
pubmed: 25453272
RSC Adv. 2020 Mar 19;10(19):11325-11334
pubmed: 35495324
Carbohydr Polym. 2018 Dec 1;201:522-531
pubmed: 30241849
Microorganisms. 2020 Jan 31;8(2):
pubmed: 32024001